Skip to main content

Intrauterine Transfusions

  • Chapter
  • First Online:
Neonatal Transfusion Practices

Abstract

Although decreased in incidence, fetal anemia remains a serious complication in pregnancy and is associated with a clinically significant perinatal mortality and morbidity. Ultrasound-guided intrauterine transfusion (IUT) is now considered to be the most successful therapy for fetal anemia secondary to red cell alloimmunization. As a result of a cumulative clinical experience, IUT has been expanded to apply as a therapy for multiple fetal indications including parvovirus B19 infection, fetomaternal hemorrhage, and placental chorioangiomas. Current indications, complications, and long-term outcomes of IUT therapy will be discussed.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

eBook
USD 16.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 74.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 84.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

Intravascular Techniques for FBS

  1. Bang J, Bock JE, Trolle D. Ultrasound guided fetal intravenous transfusion for severe rhesus hemolytic disease. Br Med J. 1982;284:373–4.

    Article  CAS  Google Scholar 

  2. Daffos F, Capella-Pavlovsky M, Forestier F. A new procedure for fetal blood sampling in utero: preliminary results of fifty-three cases. Am J Obstet Gynecol. 1983;146:985–7.

    Article  CAS  PubMed  Google Scholar 

  3. Rodeck CH, Campbell S. Umbilical cord insertion as a source of pure fetal blood for prenatal diagnosis. Lancet. 1979;1:1244–5.

    Article  CAS  PubMed  Google Scholar 

  4. Berry SM, Stone J, Norton ME, Johnson D, Berghella V. Fetal blood sampling. Am J Obstet Gynecol. 2013;209(3):170–80.

    Article  PubMed  Google Scholar 

  5. Alexander JM, Ramus R, Jackson G, Sercely B, Wendel GD. Risk of hepatitis B transmission after amniocentesis in chronic hepatitis B carriers. Infect Dis Obstet Gynecol. 1999;7:283–6.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  6. Delamare C, Carbonne B, Heim N, et al. Detection of hepatitis C virus RNA (HCV RNA) in amniotic fluid: a prospective study. J Hepatol. 1999;31:416–20.

    Article  CAS  PubMed  Google Scholar 

  7. Somigliana E, Bucceri AM, Tibaldi C, et al. Early invasive diagnostic techniques in pregnant women who are infected with the HIV: a multicenter case series. Am J Obstet Gynecol. 2005;193:437–42.

    Article  PubMed  Google Scholar 

  8. Towers CV, Asrat T, Rumney P. The presence of hepatitis B surface antigen and deoxyribonucleic acid in amniotic fluid and cord blood. Am J Obstet Gynecol. 2001;184:1514–20.

    Article  CAS  PubMed  Google Scholar 

  9. Tangshewinsirikul C, Wanapirak C, Piyamongkol W, Sirichotiyakul S, Tongsong T. Effect of cord puncture site in cordocentesis at mid-pregnancy on pregnancy outcomes. Prenat Diagn. 2001;31:861–64.

    Google Scholar 

  10. Tongsong T, Wanapirak C, Kunavikatikul C, Sirirchotiyakul S, Piyamongkol W, Chanprapaph P. Cordocentesis at 16–24 weeks of gestation: experience of 1,320 cases. Prenat Diagn. 2000;20:224.

    Article  CAS  PubMed  Google Scholar 

  11. Aina-Mumuney AJ, Holcroft CJ, Blakemore KJ, et al. Intrahepatic vein for fetal blood sampling: one center's experience. Am J Obstet Gynecol. 2008;198:387.e1–e6.

    Article  Google Scholar 

  12. Boulout P, Deschamps F, Lefort G, et al. Pure fetal blood samples obtained by cordocentesis: technical aspects of 322 cases. Prenat Diagn. 1990;10:93–100.

    Article  Google Scholar 

  13. Copel JA, Grannum PA, Harrison D, Hobbins JC. The use of intravenous pancuronium bromide to produce fetal paralysis during intravascular transfusion. Am J Obstet Gynecol. 1988;158:170–1.

    Article  CAS  PubMed  Google Scholar 

  14. Moise KJ, Deter RL, Kirshon B, Adam K, Patton DE, Carpenter RJ. Intravenous pancuronium bromide for fetal neuromuscular blockade during intrauterine transfusion for red-cell alloimmunization. Obstet Gynecol. 1989;74:905–8.

    PubMed  Google Scholar 

  15. Bernstein HH, Chitkara U, Plosker H, Gettes M, Berkowitz RL. Use of atracurium besylate to arrest fetal activity during intrauterine intravascular transfusions. Obstet Gynecol. 1988;72:813–16.

    CAS  PubMed  Google Scholar 

  16. Leveque C, Murat I, Toubas F, Poissonnier MH, Brossard Y, Saint-Maurice C. Fetal neuromuscular blockade with vecuronium bromide: studies during intravascular intrauterine transfusion in isoimmunized pregnancies. Anesthesiology. 1992;76:642–44.

    Article  CAS  PubMed  Google Scholar 

  17. Liao C, Wei J, Li Q, Li L, Li J, Li D. Efficacy and safety of cordocentesis for prenatal diagnosis. Int Gyencol Obstet. 2006;93:13–7.

    Article  Google Scholar 

  18. Boupaijit K, Wanapirak C, Piyamongkol W, Sirichotiyakul S, Tongsong T. Effect of placenta penetration during cordocentesis at mid pregnancy on fetal outcomes. Prenat Diagn. 2012;32:83–7.

    Article  PubMed  Google Scholar 

Volume Calculations

  1. Mari G, Norton ME, Stone J, Berghella V, Sciscione AC, Tate D, Schenone MH. Society for Maternal-Fetal Medicine (SMFM) Clinical Guideline #8: the fetus at risk for anemia-diagnosis and management. Am J Obstet Gynecol. 2015;212(6):697–710.

    Google Scholar 

  2. Moise KJ, Whitecar PW. Antenatal therapy for hemolytic disease. In: Hadley A, Soothill P, editors. Alloimmune disorders of pregnancy. Anemia, thrombocytopenia and neutropenia in the fetus and newborn. Cambridge, UK: Cambridge University Press; 2002.

    Google Scholar 

  3. http://perinatology.com/protocols/rhc.htm.

  4. Radunovic N, Lockwood CJ, Alvarez M, Plecas D, Chitkara U, Berkowitz RL. The severely anemic and hydropic isoimmune fetus: changes in fetal hematocrit associated with intrauterine death. Obstet Gynecol. 1992;79:390–93.

    Article  CAS  PubMed  Google Scholar 

Complications: ND Outcomes

  1. DeJong EP, Lindenberg IT, van Klink JM, Oepkes D, van Kamp IL, Wlather FJ, Lopriore E. Intrauterine transfusion for parvovirus B19 infection: long term neurodevelopmental outcome. Am J Obstet Gynecol. 2012;206:e1–5.

    Article  Google Scholar 

  2. Doyle LW, Kelly EA, Rickards AL, Ford GW, Callanan C. Sensorineural outcome at two years for survivors of erythroblastosis treated with fetal intravascular transfusions. Obstet Gynecol. 1993;81:931–5.

    CAS  PubMed  Google Scholar 

  3. Stewart G, Day RE, Del PC, Whittle MJ, Turner TL, Holland BM. Developmental outcome after intravascular intrauterine transfusion for rhesus hemolytic disease. Arch Dis Child Fetal Neonatal Ed. 1994;70:F52–3.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  4. Janssens HM, de Haan MJ, van Kemp IL, Brand R, Kanhai HH, Veen S. Outcome for children treated with fetal intravascular transfusions because of severe blood group antagonism. J Pediatr. 1997;131:373–80.

    Article  CAS  PubMed  Google Scholar 

  5. Hudon L, Moise KJ, Hegemier SE, Hill RM, Moise AA, Smith EO, et al. Long term neurodevelopmental outcome after intrauterine transfusion for the treatment of fetal hemolytic disease. Am J Obstet Gynecol. 1998;81:931–35.

    Google Scholar 

  6. Grab D, Paulus WE, Bommer A, Bucjk G, Terinde R. Treatment of fetal erythroblastosis by intravascular transfusions: outcomes at 6 years. Obstet Gynecol. 1999;93:165–8.

    CAS  PubMed  Google Scholar 

  7. Farrant B, Battin M, Roberts A. Outcomes of infants receiving in utero transfusions for hemolytic disease. N Z Med J. 2001;114:400–3.

    CAS  PubMed  Google Scholar 

  8. Harper DC, Swigle HM, Weiner CP, Bonthius DJ, Aylward GP, Widness JA. Long term neurodevelopmental outcome and brain volume after treatment for hydrops fetalis by in utero intravascular transfusion. Am J Obstet Gynecol. 2006;195:192–200.

    Article  PubMed  Google Scholar 

  9. Weisz B, Rosenbaum O, Chayen B, Peltz R, Feldman B, Lipitz S. Outcome of severely anemic fetuses treated by intrauterine transfusions. Arch Dis Child Fetal Neonatal Ed. 2009;94:F201–4.

    Article  CAS  PubMed  Google Scholar 

  10. Lindenberg ITM, Smits-Wintjens VE, Van Klink JMM, Verduin E, Van Kamp IL, Walther FJ, et al. Long term neurodevelopmental outcome after intrauterine transfusion for hemolytic disease of the fetus/newborn: the LOTUS study. Am J Obstet Gynecol. 2012;206:141.e1–8.

    Article  Google Scholar 

  11. Van Klink JMM, Koopman HM, Oepkes D, Walther FJ, Lopriore E. Long term neurodevelopmental outcome after intrauterine transfusion for fetal anemia. Early Hum Dev. 2011;87:589–93.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Nahla Khalek MD .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2017 Springer International Publishing Switzerland

About this chapter

Cite this chapter

Khalek, N. (2017). Intrauterine Transfusions. In: Sesok-Pizzini, D. (eds) Neonatal Transfusion Practices. Springer, Cham. https://doi.org/10.1007/978-3-319-42764-5_5

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-42764-5_5

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-42762-1

  • Online ISBN: 978-3-319-42764-5

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics